Cargando…
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways
Novel coronavirus SARS-CoV-2 has resulted in a global pandemic with worldwide 6-digit infection rates and thousands of death tolls daily. Enormous efforts are undertaken to achieve high coverage of immunization to reach herd immunity in order to stop the spread of SARS-CoV-2 infection. Several SARS-...
Autor principal: | Kircheis, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509779/ https://www.ncbi.nlm.nih.gov/pubmed/34639132 http://dx.doi.org/10.3390/ijms221910791 |
Ejemplares similares
-
Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins
por: Bachus, Scott, et al.
Publicado: (2022) -
Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020) -
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
por: Kusadasi, Nuray, et al.
Publicado: (2020) -
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
por: Labò, Nazzarena, et al.
Publicado: (2020) -
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)